img

Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
T-Cell & NK-Cell Engaging Bispecific Antibodies report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global T-Cell & NK-Cell Engaging Bispecific Antibodies market is projected to reach US$ 5107.7 million in 2034, increasing from US$ 472 million in 2022, with the CAGR of 41.0% during the period of 2024 to 2034. Demand from Hematological Cancers and Solid Tumors are the major drivers for the industry.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global T-Cell & NK-Cell Engaging Bispecific Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen
Immunocore
Johnson & Johnson
Roche
Pfizer
AbbVie
MacroGenics
Regeneron
Segment by Type
T-Cell Engagers
NK-Cell Engagers

Segment by Application


Hematological Cancers
Solid Tumors

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the T-Cell & NK-Cell Engaging Bispecific Antibodies market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of T-Cell & NK-Cell Engaging Bispecific Antibodies, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the T-Cell & NK-Cell Engaging Bispecific Antibodies industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, T-Cell & NK-Cell Engaging Bispecific Antibodies introduction, etc. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of T-Cell & NK-Cell Engaging Bispecific Antibodies market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Product Overview
1.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment by Type
1.2.1 T-Cell Engagers
1.2.2 NK-Cell Engagers
1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Type
1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Overview by Type (2018-2034)
1.3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size Review by Type (2018-2024)
1.3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Type (2018-2024)
1.4.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Type (2018-2024)
1.4.4 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Type (2018-2024)
2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competition by Company
2.1 Global Top Players by T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (2018-2024)
2.2 Global Top Players by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (2018-2024)
2.3 Global Top Players by T-Cell & NK-Cell Engaging Bispecific Antibodies Price (2018-2024)
2.4 Global Top Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competitive Situation and Trends
2.5.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies as of 2022)
2.7 Date of Key Manufacturers Enter into T-Cell & NK-Cell Engaging Bispecific Antibodies Market
2.8 Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 T-Cell & NK-Cell Engaging Bispecific Antibodies Status and Outlook by Region
3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Region
3.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Region (2018-2024)
3.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Region (2018-2024)
3.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Region
3.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Region (2024-2034)
3.3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Region (2024-2034)
3.3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies by Application
4.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment by Application
4.1.1 Hematological Cancers
4.1.2 Solid Tumors
4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Application
4.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Overview by Application (2018-2034)
4.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size Review by Application (2018-2024)
4.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Application (2018-2024)
4.3.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Application (2018-2024)
4.3.4 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Breakdown by Application (2018-2024)
5 North America T-Cell & NK-Cell Engaging Bispecific Antibodies by Country
5.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Country
5.1.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2018-2024)
5.1.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2018-2024)
5.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Country
5.2.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2024-2034)
5.2.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2024-2034)
6 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies by Country
6.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Country
6.1.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2018-2024)
6.1.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2018-2024)
6.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Country
6.2.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2024-2034)
6.2.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2024-2034)
7 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies by Region
7.1 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Region
7.1.1 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Region (2018-2024)
7.2 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Region
7.2.1 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Region (2024-2034)
8 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies by Country
8.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Country
8.1.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2018-2024)
8.1.3 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2018-2024)
8.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Country
8.2.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2024-2034)
8.2.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2024-2034)
9 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies by Country
9.1 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Size by Country
9.1.1 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2018-2024)
9.2 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Forecasted Market Size by Country
9.2.1 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.1.5 Amgen Recent Development
10.2 Immunocore
10.2.1 Immunocore Company Information
10.2.2 Immunocore Introduction and Business Overview
10.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.2.5 Immunocore Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.4.5 Roche Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.5.5 Pfizer Recent Development
10.6 AbbVie
10.6.1 AbbVie Company Information
10.6.2 AbbVie Introduction and Business Overview
10.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.6.5 AbbVie Recent Development
10.7 MacroGenics
10.7.1 MacroGenics Company Information
10.7.2 MacroGenics Introduction and Business Overview
10.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.7.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.7.5 MacroGenics Recent Development
10.8 Regeneron
10.8.1 Regeneron Company Information
10.8.2 Regeneron Introduction and Business Overview
10.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Products Offered
10.8.5 Regeneron Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Industrial Chain Analysis
11.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Dynamics
11.4.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Trends
11.4.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
11.4.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
11.4.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors
12.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of T-Cell Engagers
Table 2. Major Company of NK-Cell Engagers
Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (K Units)
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Type (2018-2024)
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (US& Million)
Table 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share in Value by Type (2018-2024)
Table 8. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2018-2024) & (US$/Unit)
Table 9. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2024-2034) & (K Units)
Table 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Type (2024-2034)
Table 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2024-2034) & (US$ Million)
Table 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Type (2024-2034)
Table 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2024-2034) & (US$/Unit)
Table 14. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (K Units)
Table 15. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2018-2024)
Table 17. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2018-2024)
Table 21. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Company (2018-2024) & (K Units)
Table 25. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Company (2018-2024)
Table 26. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Company (2018-2024)
Table 28. Global Market T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Company (2018-2024) & (US$/Unit)
Table 29. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies as of 2022)
Table 32. Date of Key Manufacturers Enter into T-Cell & NK-Cell Engaging Bispecific Antibodies Market
Table 33. Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2018-2024) & (K Units)
Table 37. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Region (2018-2024)
Table 38. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2018-2024) & (US$ Million)
Table 39. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Region (2018-2024)
Table 40. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2024-2034) & (K Units)
Table 42. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Region (2024-2034)
Table 43. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2024-2034) & (US$ Million)
Table 44. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Region (2024-2034)
Table 45. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) & (K Units)
Table 48. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Application (2018-2024)
Table 49. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 50. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Application (2018-2024)
Table 51. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2018-2024) & (US$/Unit)
Table 52. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2024-2034) & (K Units)
Table 53. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Application (2024-2034)
Table 54. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2024-2034) & (US$ Million)
Table 55. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Application (2024-2034)
Table 56. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2024-2034) & (US$/Unit)
Table 57. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) (K Units)
Table 58. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) (K Units)
Table 60. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) (K Units)
Table 64. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 67. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (K Units)
Table 68. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 69. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 70. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2018-2024)
Table 71. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (K Units)
Table 72. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 73. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 74. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2024-2034)
Table 75. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (K Units)
Table 76. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2018-2024)
Table 79. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (K Units)
Table 80. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (K Units)
Table 92. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (K Units)
Table 96. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Country (2024-2034)
Table 107. Amgen Company Information
Table 108. Amgen Introduction and Business Overview
Table 109. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 111. Amgen Recent Development
Table 112. Immunocore Company Information
Table 113. Immunocore Introduction and Business Overview
Table 114. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 116. Immunocore Recent Development
Table 117. Johnson & Johnson Company Information
Table 118. Johnson & Johnson Introduction and Business Overview
Table 119. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 121. Johnson & Johnson Recent Development
Table 122. Roche Company Information
Table 123. Roche Introduction and Business Overview
Table 124. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 126. Roche Recent Development
Table 127. Pfizer Company Information
Table 128. Pfizer Introduction and Business Overview
Table 129. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 131. Pfizer Recent Development
Table 132. AbbVie Company Information
Table 133. AbbVie Introduction and Business Overview
Table 134. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 136. AbbVie Recent Development
Table 137. MacroGenics Company Information
Table 138. MacroGenics Introduction and Business Overview
Table 139. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 141. MacroGenics Recent Development
Table 142. Regeneron Company Information
Table 143. Regeneron Introduction and Business Overview
Table 144. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product
Table 146. Regeneron Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Trends
Table 150. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
Table 151. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
Table 152. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
Table 153. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List
Table 154. T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream Customers
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Product Picture
Figure 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of T-Cell Engagers
Figure 6. Global T-Cell Engagers Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of NK-Cell Engagers
Figure 8. Global NK-Cell Engagers Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type in 2022 & 2034
Figure 11. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Type in 2022
Figure 12. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Type in 2022
Figure 13. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Type in 2022
Figure 14. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Type in 2022
Figure 17. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Type in 2022
Figure 18. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2022
Figure 23. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hematological Cancers
Figure 25. Global Hematological Cancers Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Solid Tumors
Figure 27. Global Solid Tumors Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application in 2022 & 2034
Figure 30. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Application in 2022
Figure 31. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Application in 2022
Figure 32. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Application in 2022
Figure 33. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Application in 2022
Figure 36. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Volume by Application in 2022
Figure 37. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Cost Structure
Figure 41. T-Cell & NK-Cell Engaging Bispecific Antibodies Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries